素代谢是乳腺癌中一种新的代谢瘤抑制途径
Jianchun Wu1, Kaitrin Kramer1, David L Crowe2
1University of Illinois Cancer Center, 801 S. Paulina Street, Room 525, Chicago, IL, 60612, USA.
Oncogene
|July 1, 2023
概括
肥胖通过改变核受体功能驱动乳腺癌. 失去过氧酶增殖器激活受体γ (PPARγ) 激活了素代谢,揭示了一种新的瘤抑制途径.
科学领域:
- 在瘤学瘤学.
- 代谢途径 代谢途径
- 分子生物学分子生物学
背景情况:
- 肥胖是乳腺癌的主要可预防的原因.
- 核受体氧体增殖器激活受体γ (PPARγ) 与肥胖有关,在乳腺癌中降低.
- 肥胖微环境对乳腺癌中的核受体的影响需要进一步研究.
研究的目的:
- 开发一种模型,阐明肥胖引起的微环境变化如何影响乳腺癌中的核受体功能.
- 研究PPARγ在与肥胖相关的乳腺癌表型中的作用.
- 为了确定参与抑制乳腺癌的新代谢途径.
主要方法:
- 创建了一个新的小鼠模型来研究肥胖对乳腺癌的影响.
- 在乳腺上皮质中利用了PPARγ的遗传删除.
- 分析了基因表达,细胞增殖,自和衰老标志物.
- 研究了2-氨基酸半合酶 (AASS) 的作用及其通过PPARγ的调节.
- 研究了AASS过度表达,乙乙酸盐和HDAC抑制在人类乳腺癌细胞系和体内细胞系中的影响.
主要成果:
- 在瘦小鼠中,PPARγ 缺失意外增加了瘤潜伏期,减少了光原细胞,增强了自和衰老.
- 肥胖小鼠中PPARγ的损失调节了AASS,这是氨酸代谢的调节者.
- 在人类乳腺癌中,AASS的表达减少;其过度表达或乙乙酸治疗抑制了增殖并诱导了自/衰老.
- 抑制HDAC促进了乳腺瘤细胞的自和衰老.
结论:
- 素代谢代表了乳腺癌中一种新的代谢瘤抑制途径.
- 在肥胖的背景下,PPARγ在调节这种途径方面发挥着关键作用.
- 向素代谢或HDACs可能为与肥胖相关的乳腺癌提供治疗策略.
相关概念视频
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


